CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 111 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,000 | -93.8% | 10,596 | -82.9% | 0.00% | – |
| Q2 2021 | $113,000 | +109.3% | 61,837 | +126.8% | 0.00% | – |
| Q1 2021 | $54,000 | +54.3% | 27,262 | -1.9% | 0.00% | – |
| Q4 2020 | $35,000 | -75.4% | 27,791 | -64.7% | 0.00% | – |
| Q3 2020 | $142,000 | -84.4% | 78,719 | -27.3% | 0.00% | -100.0% |
| Q2 2020 | $909,000 | +178.0% | 108,299 | +73.8% | 0.00% | – |
| Q1 2020 | $327,000 | +138.7% | 62,310 | +147.8% | 0.00% | – |
| Q4 2019 | $137,000 | +77.9% | 25,148 | +59.8% | 0.00% | – |
| Q3 2019 | $77,000 | -37.4% | 15,736 | -11.4% | 0.00% | – |
| Q2 2019 | $123,000 | – | 17,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |